2cn5
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
==Crystal structure of human Chk2 in complex with ADP== | ==Crystal structure of human Chk2 in complex with ADP== | ||
- | <StructureSection load='2cn5' size='340' side='right' caption='[[2cn5]], [[Resolution|resolution]] 2.25Å' scene=''> | + | <StructureSection load='2cn5' size='340' side='right'caption='[[2cn5]], [[Resolution|resolution]] 2.25Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[2cn5]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2CN5 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2CN5 FirstGlance]. <br> | <table><tr><td colspan='2'>[[2cn5]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2CN5 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2CN5 FirstGlance]. <br> | ||
Line 30: | Line 30: | ||
==See Also== | ==See Also== | ||
- | *[[Serine/threonine protein kinase|Serine/threonine protein kinase]] | + | *[[Serine/threonine protein kinase 3D structures|Serine/threonine protein kinase 3D structures]] |
== References == | == References == | ||
<references/> | <references/> | ||
Line 36: | Line 36: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Human]] | [[Category: Human]] | ||
+ | [[Category: Large Structures]] | ||
[[Category: Non-specific serine/threonine protein kinase]] | [[Category: Non-specific serine/threonine protein kinase]] | ||
[[Category: Oliver, A W]] | [[Category: Oliver, A W]] |
Revision as of 10:46, 26 February 2020
Crystal structure of human Chk2 in complex with ADP
|
Categories: Human | Large Structures | Non-specific serine/threonine protein kinase | Oliver, A W | Pearl, L H | Activation segment | Atp-binding | Cancer | Cds1 | Cell cycle | Checkpoint | Chek2 | Chk2 | Disease mutation | Kinase | Kinase domain | Li-fraumeni syndrome | Magnesium | Metal-binding | Nuclear protein | Nucleotide-binding | Phosphorylation | Proto-oncogene | Rad53 | Serine/threonine-protein kinase | Transferase | Tumour suppressor